Briston Pharmaceutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
About Briston Pharmaceutics
Briston Pharmaceutics Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2020 (Five years 5 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ashwini Tripathi, Farid Khan, and Arunesh Moitra serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33119DL2020PTC361367
-
Company No.
361367
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Feb 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Briston Pharmaceutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Tripathi
|
Director | 04-Feb-2020 | Current |
|
Farid Khan
|
Director | 04-Feb-2020 | Current |
|
Arunesh Moitra
|
Director | 04-Feb-2020 | Current |
Financial Performance of Briston Pharmaceutics.
Briston Pharmaceutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Briston Pharmaceutics?
In 2020, Briston Pharmaceutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medicate International Private LimitedAshwini Tripathi is a mutual person
-
W&B Health Care Private Limited
Ashwini Tripathi is a mutual person
-
Vikeshi Microcare Foundation
Ashwini Tripathi is a mutual person
-
Frista Pharmaceutics Private Limited
Farid Khan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Briston Pharmaceutics?
Unlock and access historical data on people associated with Briston Pharmaceutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Briston Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Briston Pharmaceutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.